Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis
BACKGROUND: Both COX-2 selective inhibitors (coxibs) and nonselective (ns)-NSAIDs elevate blood pressure (BP) and this may contribute to excess cardiovascular (CV) events. A number of recent large-scale randomized clinical trials (RCTs) comparing coxibs (including newer agents, lumiracoxib and etori...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Lippincott Williams & Wilkins
2009
|
| Online Access: | http://hdl.handle.net/20.500.11937/9160 |